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Abstract
BACKGROUND: Inflammatory bowel disease (IBD) is a chronic or relapsing inflammation of the intestine which 
consists of Crohn’s disease and ulcerative colitis. Interleukin (IL)-10 is an anti-inflammatory cytokine which plays 
important role in the pathogenesis of IBD. Neem (Azadirachta indica) is rich of azadiractoids which possesses anti-
inflammatory activity.
AIM: The objective of the study was to determine the effect of neem leaf extract on IL-10 expression and histological 
score in dextran sodium sulfate (DSS)-induced colitis rats.
METHODS: The first phase compared 7 DSS-induced colitis rats (case group) with seven healthy rats (control 
group). All of them were sacrificed. The second phase compared 28 DSS-induced colitis rats treated with mesalazine 
(Group I) and 56 rats treated with neem leaf extract (Groups II and III). Seven rats from each group were sacrificed 
on days 7, 14, 21, and 28. Colon samples were harvested and underwent histopathological examination and 
immunohistochemical analysis to determine IL-10 expression and histological score.
RESULTS: IL-10 expression and histological score were higher in case group compared to control group. There was 
similar IL-10 expression between Groups I and II on day 28 while the similarity was observed since day 7 between 
Groups I and III. Mean histological score was higher in Group II compared to Group I and it was similar between 
Group I and Group III on days 21 and 28.
CONCLUSION: Neem leaf extract increased the expression of anti-inflammatory cytokine, in particular IL-10, and 
improved histological score in DSS-induced colitis rats.
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Introduction
Inflammatory bowel disease (IBD) is a chronic 
or relapsing inflammation of the intestine which consists 
of Crohn’s disease and ulcerative colitis [1], [2]. The 
etiology of IBD is still uncertain. It is proposed that IBD 
is the result of excessive immune response toward 
gastrointestinal microorganisms marked by increased 
effector T cell activity and/or decreased regulator T 
cell activity, changed gastrointestinal microorganisms 
composition, and/or damaged epithelial barrier [3]. 
Interleukin (IL)-10 is an anti-inflammatory cytokine 
which plays important role in the pathogenesis of IBD, 
together with IL-6 and tumor necrosis factor (TNF)-α. 
IL-10 works in contradictory fashion with IL-6 and TNF-α 
by decreasing pro-inflammatory cytokines [4]. Human 
B cell expresses and produces IL-10 after appropriate 
stimulation such as infection, especially in atopic 
children [5]. The previous study reported that IL-10 
possesses anti-proliferation effect of T helper cells on 
human intestinal lamina propria [6]. In the other hand, 
antigen presenting cells produced IL-10 to regulate 
homeostatic T cell response toward commensal 
bacteria [7]. The expression of T-cell-derived IL-10 
has protective role from colitis in human by controlling 
inflammation within colonic mucosa [8].
At present, mesalazine is the drug of choice 
for IBD and is utilized to maintain remission status of 
patients with ulcerative colitis. Alternative treatments 
are corticosteroids, immunomodulatory drugs, 
biological agents, small molecular therapies, and 
immunosuppressants [2], [9]. Neem (Azadirachta 
indica) is a plant from Meliaceae family. It is native to 
India, Myanmar, Bangladesh, Sri Lanka, Malaysia, and 
Pakistan. It grows in tropical and subtropical regions 
around the globe. It is rich of azadiractoids, a highly 
active liminoid terpenoids, which possesses anti-
inflammatory and anticancer activity. The extract of 
its seed, leave, flower, and fruit has long been used 
as cancer treatment for centuries [10], [11], [12]. A 
study by Gautam et al. using neem leaf extract in 
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trinitrobenzenesulfonic acid-induced colitis rats showed 
improvement in the disease course. Neem leaf extract 
was shown to have antibacterial, antioxidant, anti-
inflammatory, and immunomodulatory activities [13].
Due to its anti-inflammatory activity, neem 
is hoped to be an alternative or adjuvant therapy for 
patients with colitis. This study aimed to determine 
the effect of neem (A. indica) leaf extract on IL-10 
expression and histological score in dextran sodium 
sulfate (DSS)-induced colitis rats.
Methods
Animals and study design
This study was conducted in Biological 
Laboratory and Anatomical Pathology Laboratory 
of Universitas Sumatera Utara, Medan, Indonesia, 
between June and September 2019. This study was 
divided into two phases. The first phase involved 14 
male healthy Wistar rats (Rattus norvegicus), aged 6–8 
weeks old and weighing 30 g, was kept at 20–25°C 
with controlled 12 h light/dark cycle. Laboratory-
standardized cages were used to keep the animals 
with ad libitum access to food and water. A half of 
them (case group) were induced by DSS for five cycles 
(70 days) to create colitis while the rest (control group) 
were left without induction. All of them were sacrificed 
and colon samples were harvested from each mouse. 
Colon samples were then fixated in phosphate-buffered 
saline 10% formalin for histopathological examination 
and immunohistochemical analysis of IL-10.
The second phase was enrolling 84 rats. All 
of them were divided into three groups. The first group 
received 7.8 mg of mesalazine daily (Group I), the second 
received 100 mg/200 g body weight of neem leaf extract 
twice daily (Group II), and the third received 200 mg/200 
g body weight of neem leaf extract twice daily (Group III) 
[14]. Seven rats from each group were sacrificed on 
days 7, 14, 21, and 28. Colon sample was harvested 
from each mouse and utilized for histopathological 
examination and immunohistochemical analysis as 
described above. All procedures were conducted 
according to Helsinki Declaration. This study had been 
approved by The Institutional Ethics Committee of the 
Universitas Sumatera Utara, Medan, Indonesia.
Chemical induction of colitis
Colitis was induced by administering 5% of 
DSS (MP Biomedicals LLC) in five cycles. Each cycle 
was conducted for 7 days and followed by distilled 
water administration for 7 days. After five cycles with a 
total of 70 days, the rats were sacrificed or treated with 
either mesalazine or neem leaf extract.
Histopathological examination
Colon samples were stained using hematoxylin 
and eosin (H&E) after being paraffin-embedded and 
cut. H&E-stained colonic sections were coded for blind 
microscopic assessment of inflammation (i.e., DSS-
induced colitis). Histological scoring was based on three 
parameters. Severity of inflammation was scored as 
follows: 0 – rare inflammatory cells in the lamina propria; 
1 – increased numbers of granulocytes in the lamina 
propria; 2 – confluence of inflammatory cells extending 
into the submucosa; and 3 – transmural extension of the 
inflammatory infiltrate. Crypt damage was scored as follows: 
0 – intact crypts; 1 – loss of the basal one-third; 2 – loss of the 
basal two-thirds; 3 – entire crypt loss; 4 – change of epithelial 
surface with erosion; and 5 – confluent erosion. Ulceration 
was scored as follows: 0 – absence of ulcer; 1–1 or 2 foci 
of ulcerations; 2–3 or 4 foci of ulcerations; and 3 – confluent 
or extensive ulceration. Values were calculated to give a 
maximal histological score of 11 [15].
Immunohistochemical analysis of IL-10
The paraffin-embedded slides were 
deparaffinized, rehydrated, and heated on microwave 
with 0.01 M citrate buffer (pH 6.0) for 30 min. Endogen 
peroxidase activity was blocked with 3% hydrogen 
peroxide for 10 min, and then washed with sulfate 
salt buffer. The specimens were incubated overnight 
in 4°C, then immune-stained with primary antibody 
(rabbit polyclonal IgG to bind the rats IL-10) (Wuhan 
Fine Biotech Co., Ltd., China) in concentration of 
1 mg/mL diluted by 1:600. Primary antibody was 
detected by avidin-biotin peroxidase solution (ScyTek 
Laboratories, Inc., USA) and signal was visualized using 
diaminobenzidine (ScyTek Laboratories, Inc., USA). 
The slides then counterstained with hematoxylin and 
assessed by two-blinded experienced pathologists from 
the anatomical pathology Department of Universitas 
Sumatera Utara. The slides were categorized as 0 
for 0–15%, 1 for 15–25%, 2 for 26–50%, and 3 for 
51–100% stained cells for IL-10 (Figure 1). Scale 0 and 
Figure 1: Immunohistochemical analysis of interleukin (IL)-10 results. 
From upper left to lower left slides in clockwise order showed category 
0 to 3 of IL-10 expression, sequentially
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1 was categorized as negative, while scale 2 and 3 as 
positive [16].
Statistical analysis
Fisher’s exact test was used to determine 
the difference in IL-10 expression between case and 
control group in the first phase of study. We also 
conducted Mann–Whitney test to analyze the difference 
in histological score between both groups. Data from 
the second phase were analyzed with Fisher’s exact 
test for IL-10 expression and independent t-test for 
histological score between the three groups. Statistical 
analysis was conducted at 95% confidence interval 
where p <0.05 was considered significant.
Results
Phase 1
The positive expression of IL-10 based on 
immunohistochemical analysis was significantly higher 
in the case group compared to control group (p = 0.005). 
All rats in the case group expressed IL-10 compared 
to one mouse in the control group. In addition, median 
histological score from histopathological examination 
was significantly higher in case group compared to 
control group (8 vs. 0, p = 0.001) (Table 1).
Phase 2
Further analysis was conducted to determine 
the difference in IL-10 expression and histological score 
among the three groups with different interventions. 
For the expression of IL-10, there were significant 
differences between Group I and Group II on day 7 
(p = 0.029), 14 (p = 0.021), and 21 (p = 0.021). The 
difference was not observed on day 28. There was 
no difference of IL-10 expression between Group I 
and Group III. It can be inferred that anti-inflammatory 
expression is similar in colitis rats after being treated 
with both mesalazine and 200 mg/200 g body weight of 
neem leaf extract (Table 2).
We observed significant differences in mean 
histological score between Group I and Group II on day 7 
until day 28. There were significant differences between 
Group I and Group III on day 7 (p = 0.009) and day 14 
(p = 0.024). No difference was observed on days 21 and 
20 between those groups. This means that histological 
score in colitis rats is similar after receiving mesalazine 
and 200 mg/200 g body weight for 3 weeks (Table 3).
Discussion
Ulcerative colitis is an idiopathic, chronic, and 
incurable inflammatory disease affecting colon. Its 
incidence is high in Western countries. In the past two 
decades, its incidence is rising in Asia and Middle East 
with a rate of 0.15–6.5 per 100,000 population. The 
peak incidence of ulcerative colitis occurs at the age 
of 20–39 years and 70–79 years. Ulcerative colitis is 
more common in males compared to females [2]. Colitis 
raises from several underlying conditions. Abnormal 
bacterial composition and reduced biodiversity defect 
in local defense mechanism, and dysregulated immune 
response plays an important role in the pathogenesis 
of colitis. Dysregulated immune system here means 
an imbalance between pro- and anti-inflammatory 
substances [17], [18], [19]. The damage of intestinal 
epithelial barrier, as the local defense mechanism, allows 
intestinal microorganisms to reach the deeper part of 
intestine and trigger inflammation which is responsible 
for colitis. IL-10 as an anti-inflammatory cytokine works 
to maintain gastrointestinal homeostasis by decreasing 
the production of pro-inflammatory cytokines such as 
IL-6, IL-12, and TNF-α [2], [20]. Decreased or absent of 
IL-10 increased the risk of colitis in the previous study [18]. 
Imbalance between anti- and pro-inflammatory cytokines 
leads to more severe inflammation and colitis. Chronic 
colitis will increase the risk of developing colorectal 
carcinoma [2], [20]. In the first phase of our study, all rats 
in the case group expressed IL-10 and had higher median 
histological score compared to control group. This was in 
accordance with colitis features as stated in the previous 
literatures.
Table 2: The difference of IL-10 expression among Groups I, II, 
and III
Day Group I  
n (%)
Group II  
n (%)
p  
Group I 
versus II
Group III  
n (%)
p Group I 
versus III
2 and 3 0 and 1 2 and 3 0 and 1 2 and 3 0 and 1
7 6 (85.7) 1 (14.3) 1 (14.3) 6 (85.7) 0.029* 2 (28.6) 5 (71.4) 0.103
14 7 (100) 0 (0) 2 (28.6) 5 (71.4) 0.021* 5 (71.4) 2 (28.6) 0.462
21 7 (100) 0 (0) 2 (28.6) 5 (71.4) 0.021* 6 (85.7) 1 (14.3) 1.000
28 7 (100) 0 (0) 3 (42.9) 4 (57.1) 0.070 6 (85.7) 1 (14.3) 1.000
*p < 0.05.
Chronic and recurrent nature of ulcerative 
colitis burdens the health-care resources for treatment. 
Mesalazine is the standard therapy for inducing and 
maintaining remission in colitis by modulating the 
Table 1: The difference of IL-10 expression and histological 
score between case and control groups
Variables Case group Control group p
IL-10 expression, n (%)
0 and 1
2 and 3
0 (0.0)
7 (100.0)
6 (85.7)
1 (14.3)
0.005*
Median histological score, (min-max) 8 (6 – 9) 0 (0 – 1) 0.001*
*p < 0.05.
Table 3: The difference of histological score among 
Groups I, II, and III
Day Group I
Mean (SD)
Group II
Mean (SD)
p Group I 
versus II
Group III
Mean (SD)
p Group I versus 
III
7 3.1 (1.46) 7.86 ± 1.35 <0.001* 5.29 ± 0.11 0.009*
14 2.1 (0.9) 5.14 ± 1.34 <0.001* 3.29 ± 0.77 0.024*
21 1.71 ± 0.49 3.71 ± 1.11 0.002* 2.43 ± 0.57 0.109
28 1.29 ± 0.28 2.86 ± 0.69 <0.001* 1.71 ± 0.76 0.232
*p < 0.05, SD: Standard deviation.
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inflammatory cascade. However, alternative or adjuvant 
therapy is needed to achieve better outcome [2]. Anti-
inflammatory property of neem tree is a promising 
alternative or adjuvant therapy for colitis [12].
Morris et al. in their study reported that neem 
extract had significant anticancer effect in oral squamous 
cell carcinoma. This effect was suggested from the role 
of neem extract in reducing pro-inflammatory cytokines 
including IL-6 and TNF-α [10]. Patel et al. also found that 
neem extract had anti-inflammatory property. Their study 
regarding neem extract for rats with colon cancer treatment 
showed that cyclooxygenase-1, IL-6, and TNF-α were 
significantly decreased after the treatment [12]. Neem leaf 
extract was also found to increase the activity of natural 
killer cells. These cells are potent cytotoxic cells particularly 
against virus-infected cells, intracellular parasites, and 
tumor cells by increasing production of IL-12 [21]. This 
study showed an increase of anti-inflammatory cytokines 
(IL-10) in neem leaf extract colitis rats comparable with 
mesalazine as gold standard treatment. Further study 
is needed to assess the inflammatory cytokines profile 
in neem leaf extract colitis rats. This study showed that 
IL-10 expression in Group I and II was different in the 
first 3 weeks. The number of rats which expressed IL-10 
in Group II was lower compared to Group I. In the other 
hand, IL-10 expression was different between Group I 
and III only in the 1st week. From the second until the 4th 
week of administration, the expression of IL-10 between 
both groups was comparable.
Histopathological feature was also improved 
by administration of neem leaf extract. Gautam et al. 
examined colon specimen of trinitrobenzenesulfonic 
acid-induced colitis rats after administration of 50% 
neem leave extract. The result showed improvement 
histopathological finding comparable to sulfasalazine as 
control [13]. This is concordance to the result of this study 
that shows no significant differences between Group I 
and Group III since the 1st week. No significant differences 
found between Group I and Group II only in 4th week of 
administration. This confirms that mesalazine is still the 
primary choice of treatment in patients with colitis [22].
As the conclusion, neem leaf extract increased 
the expression of anti-inflammatory cytokine, particularly 
IL-10, and improved histological score in DSS-induced 
colitis rats. However, these effects were achieved with 
a higher dose of neem leaf extract (200 mg/200 g body 
weight). Studies regarding the combination of mesalazine 
and neem leaf extract for colitis treatment are mandatory to 
determine the role of neem leaf extract as adjuvant therapy.
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